Market Overview

Goldman Removes Surgical Care Affiliates From Buy List

Goldman Removes Surgical Care Affiliates From Buy List

Goldman Sachs has downgraded Surgical Care Affiliates Inc (NASDAQ: SCAI) to Neutral from Buy on valuation.

"While we believe SCAI is well positioned to continue benefiting from secular industry trends — including the shift from inpatient to outpatient and more integrated delivery of healthcare — we believe much of this upside is now 'priced in' at current levels," analyst Matthew Borsch wrote in a note.

Related Link: Surgical Care Affiliates, SwiftPath Partner To Provide Outpatient Joint Replacement Support Services

Since being added to the Buy list on December 17, 2015, the analyst said shares rose +21 percent versus XLV -2 percent, SPX +2 percent and RUT +2 percent.

Borsch highlighted the company's focus on growth from complex spine/orthopedic procedures and appetite for exploring innovative partnerships with health plans and risk bearing medical groups.

The analyst maintains his 2016 EPS/revenue target of $2.16/$1.244 billion and reiterated his $48 price target on the stock.

At the time of writing, shares of Surgical Care Affiliates were down 4.21 percent at $46.44.

Latest Ratings for SCAI

Jan 2017Initiates Coverage OnNeutral
Jun 2016DowngradesBuyNeutral
Feb 2016MaintainsBuy

View More Analyst Ratings for SCAI
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Downgrades Health Care Price Target Analyst Ratings Trading Ideas General Best of Benzinga


Related Articles (SCAI)

View Comments and Join the Discussion!

Karyopharm Commences First Stage Clinical Study With KPT-9274

The Big Yawn: Investors Huddle on Sidelines Ahead of Brexit Vote